Take a fresh look at your lifestyle.

Dr Reddy’s announces commercial launch of 2-DG

Dr. Reddys, a leading multinational pharmaceutical company today announced the commercial launch of 2-deoxy-D-glucose (2-DG). Dr. Reddy’s will supply to major Government as well as private hospitals across the country.

In the initial weeks, the Company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the other parts of the country.

The 2-DG manufactured by Dr. Reddy’s has a purity of 99.5 per cent and is being sold commercially under the brand name 2DGTM.

Midle of the post

The maximum retail price (MRP) of each sachet has been fixed at  990 rupees , with a subsidized rate offered to Government institutions. Enquiries for 2DGTM can be sent to

2DG@drreddys.com.

2-DG was developed by the Institute of Nuclear Medicine and  Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy’s. 2-DG is an oral drug. It can be administered only upon preion and under the supervision of a qualified physician to hospitalised moderate to severe COVID-19 patients as an adjunct therapy to the existing standard of care. Emergency use approval for anti-COVID-19 therapeutic application of the drug was granted on May 1.

Leave A Reply

Your email address will not be published.